Mg OSTEOCRETE Post-Treatment Outcomes
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorSantiago Lozano-Calderon
About this trial
Mg OSTEOCRETE is a bone substitute used to fill a defect in bone caused by excision of a tumor, orthopaedic hardware that has become loosened, or a trauma-related condition. The aim of this study is to determine the amount of time it takes for bone to heal after treatment with Mg OSTEOCRETE, and to better understand the efficacy of this treatment through clinical and patient-reported outcomes.
Eligibility criteria
Qualifiers
18 years of age and older on the day of surgery
has received or will receive Mg OSTEOCRETE as a component of their treatment at this institution in accordance with Instructions for Use for the implanted product
as a bone void filler following bone tumor resection, or;
as an augment for defects causing aseptic loosening of orthopaedic implants, or;
Disqualifiers
any contraindication as per Instructions for Use for Mg OSTEOCRETE
Trial design
Treatments tested in this trial
- Mg OSTEOCRETE as a bone void filler
- Mg OSTEOCRETE as a bone void filler
- Mg OSTEOCRETE as a bone void filler
Treatment groups
10 Participants
are divided into 3 treatment groupsSponsors and collaborators
Santiago Lozano-Calderon
Lead sponsor
Massachusetts General Hospital
Sponsor institution
Bone Solutions Inc
Collaborator
Source ClinicalTrials.gov